Revvity's shares rose 7% after the company raised its full-year pro forma adjusted earnings per share guidance to a range of $5.40-$5.45, up from $5.30-$5.40. Pfizer's stock remained flat after reporting third-quarter earnings of 87 cents per share on revenue of $16.58 billion, surpassing analyst expectations of 73 cents per share and $15.87 billion in revenue.
Zebra Technologies saw a decline of over 6% despite reporting earnings of $4.95 per share and revenue of $1.61 billion, both exceeding analyst forecasts, although its free cash flow guidance fell slightly short of expectations. Gartner's shares also dropped over 6% despite beating third-quarter expectations and providing positive full-year guidance.
Yum Brands gained 1% after reporting adjusted earnings of $1.56 per share, above the expected $1.49, with revenue of $2.05 billion meeting consensus estimates. Palantir Technologies' shares fell nearly 8% despite a 148% increase in U.S. commercial revenue to $984 million, projecting $2.65 billion in fourth-quarter revenue and $8.53 billion for full-year 2026.
Apple shares dropped nearly 4% following a disappointing margin forecast and lower-than-expected iPad sales in the fiscal fourth quarter